Register entry
- Registered sites
- 1
- Active NDC listings
- 27
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Catalent Indiana, LLC | 1300 S. Patterson Drive, Bloomington, Indiana (IN) 47403, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3005949964172209277 |
Catalogue
Drug listings by form and route
2727 active NDC listings: 17 human prescription drug, 9 drug for further processing, 1 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 23, EXPORT ONLY 3, BULK INGREDIENT 1.
| Dosage form | NDCs |
|---|---|
| injection, solution | 17 |
| injection | 7 |
| injection, powder, lyophilized, for solution | 2 |
| solution | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| catalent indiana, llc | 27 |
Catalogue
Marketed products
27| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Aflibercept | injection, solution | 61434-077EXPORT ONLY |
| - | Benralizumab | injection, solution | 61434-066DRUG FOR FURTHER PROCESSING |
| - | Cemiplimab | injection | 61434-021DRUG FOR FURTHER PROCESSING |
| - | Diluent | solution | 61434-011DRUG FOR FURTHER PROCESSING |
| - | Durvalumab | injection, solution | 61434-038DRUG FOR FURTHER PROCESSING |
| - | Epinephrine | injection | 61434-040DRUG FOR FURTHER PROCESSING |
| - | Epinephrine | injection | 61434-041DRUG FOR FURTHER PROCESSING |
| - | Imetelstat sodium | injection, powder, lyophilized, for solution | 61434-069DRUG FOR FURTHER PROCESSING |
| - | Odronextamab | injection, solution | 61434-064EXPORT ONLY |
| - | Odronextamab | injection, solution | 61434-072EXPORT ONLY |
| - | adalimumab | injection, solution | 61434-020DRUG FOR FURTHER PROCESSING |
| - | aflibercept | injection, solution | 61434-007DRUG FOR FURTHER PROCESSING |
| - | aflibercept | injection, solution | 61434-062DRUG FOR FURTHER PROCESSING |
| - | aflibercept | injection, solution | 61434-073DRUG FOR FURTHER PROCESSING |
| - | aflibercept | injection, solution | 61434-074DRUG FOR FURTHER PROCESSING |
| - | ansuvimab-zykl | injection | 61434-070DRUG FOR FURTHER PROCESSING |
| - | ansuvimab-zykl | injection, powder, lyophilized, for solution | 61434-071DRUG FOR FURTHER PROCESSING |
| - | atoltivimab, maftivimab, and odesivimab | injection, solution | 61434-052DRUG FOR FURTHER PROCESSING |
| - | durvalumab injection, solution | injection, solution | 61434-002DRUG FOR FURTHER PROCESSING |
| - | eteplirsen | injection | 61434-003DRUG FOR FURTHER PROCESSING |
| - | eteplirsen | injection | 61434-035DRUG FOR FURTHER PROCESSING |
| - | nivolumab | injection, solution | 61434-075DRUG FOR FURTHER PROCESSING |
| - | pozelimab | injection, solution | 61434-063DRUG FOR FURTHER PROCESSING |
| - | rHuPH20 | injection | 61434-024BULK INGREDIENT |
| - | ravulizumab | injection, solution | 61434-076DRUG FOR FURTHER PROCESSING |
| - | semaglutide | injection, solution | 61434-067DRUG FOR FURTHER PROCESSING |
| - | semaglutide | injection, solution | 61434-068DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
2- Bamboo US BidCo LLCBloomington, IN
- Cook IncorporatedBloomington, IN
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Catalent Indiana, LLC FDA approved?
- Catalent Indiana, LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Catalent Indiana, LLC's drugs manufactured?
- The FDA register lists Bloomington, IN. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
- What drugs does Catalent Indiana, LLC make?
- 27 products are listed under Catalent Indiana, LLC in the openFDA NDC Directory, most often as injection, solution; injection; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.